FDA Approves New Sunscreen Ingredient, Alcohol Guidelines Politicized Debate, NSF Laser Breakthroughs Drive Growth, Breakthrough Meningioma Study Promises Personalised Treatment, and more...

FDA Approves New Sunscreen Ingredient, Alcohol Guidelines Politicized Debate, NSF Laser Breakthroughs Drive Growth, Breakthrough Meningioma Study Promises Personalised Treatment, and more...

From Science News Daily by brief.news

June 10, 2026 · 11 min

About this episode

The episode discusses recent FDA approvals, the politicization of alcohol guidelines, advancements in laser technology, and breakthroughs in cancer treatment.

(0:10): FDA Approves New Sunscreen Ingredient BEMT, First in Over Two Decades (2:04): Alcohol Study Sparks Debate: Are Moderate Drinking Guidelines Influenced by Politics and Industry? (4:34): NSF Laser Innovations: From Medical Breakthroughs to Quantum Research and Economic Growth (6:38): Breakthrough Meningioma Study Reveals Tumor Microenvironment as Key to Personalized Treatment and Prognosis (8:22): Daraxonrasib Doubles Survival in Metastatic Pancreatic Cancer: A Breakthrough in KRAS Mutation Therapy To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: WSOC TV

Topics covered

  • sunscreen approval
  • alcohol guidelines
  • laser innovations
  • meningioma study
  • pancreatic cancer treatment

Keywords

  • FDA
  • sunscreen
  • alcohol guidelines
  • NSF
  • laser breakthroughs
  • meningioma
  • Daraxonrasib
  • pancreatic cancer

Mentioned in this episode

Organizations: FDA, NSF, WSOC TV, brief.news

Products: BEMT, Daraxonrasib

More episodes of Science News Daily

Explore listener stats, chart rankings, contacts and more on the Science News Daily podcast page.